LaMorte v. Commissioner of Social SecurityLaMorte v. Commissioner of Social Security
MEMORANDUM & ORDER
NINA R. MORRISON, United States District Judge:
In this case, Plaintiff Angelo LaMorte (“Plaintiff”) challenges the Commissioner of Social Security’s April 7, 2023 decision to deny in part Plaintiff’s August 2020 application for Social Security Disability benefits. Plaintiff and the Commissioner have both moved for judgment on the pleadings. See Pl. Mot., ECF No. 8; Comm’r Mot., ECF No. 11. For the reasons outlined below, Plaintiff’s motion is denied, and the Commissioner’s motion is granted.
BACKGROUND
Plaintiff applied for disability benefits with the Social Security Administration (“SSA”) on August 17, 2020, claiming a period of disability beginning November 19, 2019 due to kidney disease with renal auto-transplant, bilateral hip pain, and back pain. AR 11,1 231. Plaintiff reported experiencing back and hip pain beginning in 1994 and kidney pain in 2019. AR 241. Following his initial application, but prior to
Plaintiff’s claim was initially denied in June 2021, AR 67–80, 103–16, but, upon reconsideration in April 2022, Plaintiff was entitled to disability insurance benefits for the period from November 19, 2019 to June 24, 2021 because his kidney disease met the criteria of Listing 6.09, Complications of chronic kidney disease, AR 81–99, 118–31. Plaintiff then requested a hearing before an ALJ in order to challenge the June 25, 2021 disability end date. AR 134–42. Plaintiff and his counsel appeared for a hearing before an ALJ on March 28, 2023. AR 11, 39–66.
In a decision dated April 7, 2023, the ALJ found that Plaintiff was disabled from November 19, 2019 to June 24, 2021 but that the disability ended thereafter. AR 15–22. In reaching this decision, the ALJ proceeded through the five-step analysis set forth in
Plaintiff then timely filed this action. Plaintiff filed his motion for judgment on the pleadings on May 22, 2024, supported by a memorandum of law. Pl. Mem. of L. (“Pl. Mem.”), ECF No. 8-1. Defendant filed its motion for judgment on the pleadings on September 11, 2024, also supported by a memorandum of law. Def.
STANDARD OF REVIEW
Claimants who are denied disability insurance benefits by the SSA may seek judicial review.
“Under the substantial-evidence standard, a court looks to an existing administrative record and asks whether it contains ‘sufficien[t] evidence’ to support the agency’s factual determinations.” Biestek v. Berryhill, 587 U.S. 97, 102 (2019) (citation omitted). “[W]hatever the meaning of ‘substantial’ in other contexts, the threshold for such evidentiary sufficiency is not high.” Id. at 103. “It means—and means only—‘such relevant evidence as a reasonable mind might accept as adequate to support a conclusion.’” Id. (citation omitted). It is “more than a mere scintilla.” Id. (citation omitted). In applying the substantial-evidence standard, the Court must “defer[] to the presiding ALJ, who has seen the hearing up close.” Id. at 108. If substantial evidence supports the Commissioner’s findings, they are conclusive and must be upheld.
DISCUSSION
The Court has reviewed the pleadings and the administrative record in light of the applicable law. Plaintiff’s motion for judgment on the pleadings is denied, and the Commissioner’s motion is granted.
This dispute revolves around the ALJ’s determination that Plaintiff experienced medical improvement as of June 25, 2021 such that he was no longer disabled within the meaning of the SSA’s regulations after that date. Plaintiff raises two arguments. First, Plaintiff asserts that the ALJ’s determination that medical improvement occurred as of June 25, 2021 is not supported by substantial evidence. Pl. Mem. at 14–15. Second, Plaintiff asserts that the ALJ erred in his assessment of Plaintiff’s reports of his symptom intensity. Id. at 16–17.
However, as explained below, the Commissioner (1) appropriately evaluated and explicitly discussed the medical evidence supporting a finding of medical improvement on June 25, 2021, including the opinions of various physicians who examined and/or treated Plaintiff; and (2) appropriately weighed Plaintiff’s subjective reports of his symptom intensity against the record as a whole.
I. The ALJ’s Finding of Medical Improvement Is Supported by Substantial Evidence
Under the SSA’s regulations, “[m]edical improvement is defined as any decrease in the medical severity of a claimant’s impairment which was present at the time of the most recent favorable medical decision that he or she was disabled or
Plaintiff argues that the ALJ improperly “relied on his own interpretation of [Plaintiff’s] medical records to conclude that [Plaintiff] improved to the point where he was no longer disabled.” Pl. Mem. at 15. Plaintiff also asserts that the ALJ, in concluding that Plaintiff experienced medical improvement as of June 25, 2021, erred in considering the arthroscopic knee repair and epidural injection Plaintiff received in June and August 2022, respectively, both of which occurred approximately one
While the ALJ’s decision notes that Plaintiff had several severe impairments, including back and knee ailments and kidney disease, AR 15, the closed period of disability from November 19, 2019 to June 24, 2021 was based upon a finding that Plaintiff met the criteria for Listing 6.09, Complications of chronic kidney disease, AR 15–17. As to Plaintiff’s kidney disease, the ALJ’s opinion explicitly discussed the treatment records of urologist Dr. Ojas Shah in finding that medical improvement occurred as of June 25, 2021. AR 18. The ALJ also concluded that “[t]he medical improvement that has occurred is related to the ability to work because [Plaintiff] no longer has an impairment or combination of impairments that meets or medically equals the severity of a listing.” Id. (citing
However, in evaluating whether an ALJ’s conclusion is supported by substantial evidence, a reviewing court may “look to other portions of the ALJ’s decision and to clearly credible evidence in finding that his determination was supported by substantial evidence.” Mongeur v. Heckler, 722 F.2d 1033, 1040 (2d Cir. 1983) (quoting Berry v. Schweiker, 675 F.2d 464, 469 (2d Cir. 1982)); see also id.
As Defendant observes, the SSA’s regulations provide that a person who receives a kidney transplant is considered disabled under Listing 6.04 for one year following the date of the transplant procedure. Def. Mem. at 18 n.6 (quoting
These records do not document any hospitalizations or complications related to Plaintiff’s kidney disease, any rejection episodes experienced following the June 2020 auto-transplant, or any adverse effects relating to ongoing treatment. Accordingly, the ALJ committed no error in finding that Plaintiff’s kidney disease, which served as the basis for the finding of a closed period of disability from November 19, 2019 to June 24, 2021, had improved as of June 25, 2021, the date when Plaintiff’s post-transplant disability ended under Listing 6.04.
As to Plaintiff’s back ailments, the ALJ considered the results of an orthopedic exam conducted by Dr. Andrea Pollack on April 21 2021. AR 16–17. The ALJ appropriately analyzed these records and found Dr. Pollack’s opinion only partially persuasive. Id. The ALJ also considered treatment records from neurologist Dr. Salvatore Palumbo dated November 2020 to March 2021, which indicated an unremarkable examination of Plaintiff in which Plaintiff did not appear in acute distress, had no pain with lumbar or hip palpitation, and had normal muscle tone and strength with intact sensation. AR 19. These records indicated that, as of December 1, 2020, Plaintiff was “discharged from physical therapy secondary to minimal functional limitations” and had “obtained physical therapy goals.” AR 503. Plaintiff returned to Dr. Palumbo on December 14, 2020 for a “follow-up of his back pain and intermittent leg numbness.” AR 516. At this exam, Plaintiff “report[ed]
The ALJ also considered treatment records from pain management specialist Dr. Brian Goldstein dated June and July 2022. AR 20–21. These records indicate that Plaintiff received an epidural steroid injection on June 27, 2022 to address his back pain. Id. Following the injection, Plaintiff appeared in no acute distress, had no lumbar spasm or tenderness, a full range of motion with no pain, and full muscle strength in both legs with intact sensation and a non-antalgic gait. Id. Plaintiff reported an “80 to 90% relief and improved activities of daily life.” AR 21, 704.
As to Plaintiff’s knee ailment, notably, Plaintiff did not list this injury as a condition limiting his ability to work when he initially applied for disability benefits. AR 231. Moreover, the April 21, 2021 examination by Dr. Pollack involved no reports by Plaintiff of a specific right knee injury, AR 545, and did not produce any diagnosis related to his right knee, AR 547. The right knee meniscus tear referenced in the ALJ’s decision, AR 15, first appears in Plaintiff’s treatment records following a May 17, 2022 MRI, AR 698. Treatment records from orthopedist Dr. Charles Milchteim dated June 10, 2022 describe a “[c]omplex tear of [Plaintiff’s] medial meniscus of right
Having carefully reviewed the ALJ’s decision and the supporting administrative record, the Court finds that the ALJ’s determination that Plaintiff experienced medical improvement as of June 25, 2021 is supported by substantial evidence. The record contains ample support for a finding of medical improvement related to Plaintiff’s ability to work with regards with Plaintiff’s kidney disease, which no longer satisfied a Section 6.00 listing one year after Plaintiff’s June 24, 2020 kidney auto-transplant. As to Plaintiff’s back pain, Dr. Palumbo’s treatment records dated March 2021 indicate general medical improvement, even if treatment did not completely eradicate Plaintiff’s lower back ailment. See Crowell v. Astrue, No. 08-CV-8019 (LTS) (DF), 2011 WL 4863537, at *5 (S.D.N.Y. Oct. 12, 2011) (“The medical improvement standard does not require that a claimant experience a full or even substantial recovery.”). Finally, as to Plaintiff’s right knee ailment, the record does not indicate that this injury was present at the time of either Plaintiff’s disability onset date of November 19, 2019 or the date his disability ended, on June 25, 2021. Cf. Brown v. Chater, 932 F. Supp. 71, 75 (S.D.N.Y. 1996) (holding that evidence
II. The ALJ Appropriately Weighed Plaintiff’s Subjective Reports of His Symptom Intensity in Light of the Record as a Whole
Following a finding of medical improvement, if residual impairments are severe, the ALJ must then make a finding as to Plaintiff’s RFC and determine whether there is other work in the national economy in which Plaintiff can engage, notwithstanding his functional limitations. Nascimento, 90 F. Supp. 3d at 54. The ALJ here engaged in such an RFC analysis. AR 18–22. Plaintiff only contends that the ALJ erred in finding that Plaintiff’s self-reports of the intensity, persistence, and limiting effects of his symptoms were not entirely consistent with the medical and other evidence in the record. Pl. Mem. at 16–17; id. at 17 (citing AR 19).
“[I]t is well accepted that an ALJ’s assessment of an individual’s subjective complaints regarding pain and other symptoms is entitled to substantial deference by a reviewing court.” Terri M. D. v. Comm’r of Soc. Sec. Admin., No. 24-CV-801 (DEP), 2025 WL 2370953, at *7 (N.D.N.Y. Aug. 14, 2025) (citing Aponte v. Sec. of Dep’t of Health & Hum. Servs., 728 F.2d 588 (2d Cir. 1984)). Here, the ALJ engaged in a substantial analysis of the inconsistencies between Plaintiff’s self-reports of pain and limitations as compared to the medical evidence in the record. AR 19–21. The Court has already considered this medical evidence supra and, in light of deference afforded to the ALJ’s assessment of Plaintiff’s subjective complaints, finds this assessment is supported by substantial evidence. The ALJ’s RFC determination is otherwise supported by substantial evidence and free of legal error.
CONCLUSION
The Court has considered the other arguments raised and implied by Plaintiff’s briefs and finds them unpersuasive. For the foregoing reasons, Plaintiff’s motion for judgment on the pleadings is denied, and the Commissioner’s cross-motion is granted.
SO ORDERED.
/s/ Nina R. Morrison
NINA R. MORRISON
United States District Judge
Dated: August 6, 2026
Brooklyn, New York